<title>High-sensitivity imaging method of singlet oxygen and superoxide anion in photodynamic and sonodynamic actions</title>

Da Xing,Yonghong He,Min Hao,Qun Chen
DOI: https://doi.org/10.1117/12.572049
2004-01-01
Abstract:A novel method of photodynamic diagnosis (PDD) of cancer mediated by chemiluminescence (CL) probe is presented. The mechanism for photodynamic therapy (PDT) involves reactive oxygen species (ROS), such as singlet oxygen (<sup>1</sup>O<sub>2</sub>) and superoxide (O<sub>2</sub><sup>-</sup>), generated by during the photochemical process. Both <sup>1</sup>O<sub>2</sub> and O<sub>2</sub><sup>-</sup> can react with <i>Cypridina luciferin</i> analogue (FCLA), a highly selective CL probe for detecting the ROS. Chemiluminescence from the reaction of FCLA with the ROS, at about 530 nm, was detected by a highly sensitive ICCD system. The CL was markedly inhibited by the addition of 10 mmol/L sodium azide (NaN<sub>3</sub>) in a sample solution. Similar phenomena, with lesser extents of changes, were observed at the additions of 10 μmol/L superoxide dismutase (SOD), 10 mmol/L mannitol, and 100 μg/mL catalase, respectively. This indicates that the detected CL signals were mainly from ROS generated during the photosensitization reactions. Also, the chemiluminescence method was used to detect the ROS during sonodynamic action, both <i>in vitro</i> and <i>in vivo</i>. ROS formation during sonosensitizations of HpD and ATX-70 were detected using our newly-developed imaging technique, in real time, on tumor bearing animals. This method can provide a new means in clinics for tumor diagnosis.
What problem does this paper attempt to address?